US$ 29.55
tesamorelin aod9604 cjc1295 ipamorelin 12mg blend dosage + 6mg Research Peptide Tesamorelin, CJC-1295 (no DAC), Ipamorelin
Description
Integrated Research Applications AOD9604 started as a fat metabolism compound but has since opened up a second research direction in joint and cartilage biology: The bulk of AOD9604 research sits here

This might involve keeping tabs on their progress, assessing how well the treatment is working, and making any necessary adjustments to the dosage
[DOI] [PubMed] [Google Scholar] 77.Bello NT, Zahner MR

There was no presence of anti-AOD9604 antibodies detected, and no serious side effects were noted
